Kang Byeong-uk
Kyungpook National University Hospital Chilgok|Hematology and Oncology
Daegu Buk-gu
Last updated
소화기암 비뇨기암 분야에 특화된 연구가 칠곡경북대학교병원 혈액종양내과 임상활동이 뒷받침하는 전문 진료임
Medical opinions · Patient reviews0
No reviews yet.
If you've been treated by Kang Byeong-uk, be the first to leave a review.
Planning to see Kang Byeong-uk?
Save this doctor and find them again anytime on My page.
Ask other patients
If reviews don't answer your questions, ask patients and caregivers who have been there.
Patient stories: Hematology and Oncology
MoreHospital information
- Specialties
- More Hematology and Oncology doctors
- Address
- 807 Hoguk-ro, Buk-gu, Daegu
- University
- 경북대학교 의과대학
- Appointments
- 1533-8888Book by phone (1533-8888)
Education and career
Career
- 2008년 2월 : 서울아산병원 내과 전공의 수료 및 전문의 취득2008년 3월 - 2009년 2월 : 서울아산병원 종양내과 임상강사2009년 11월 2009년 12월: 일본 게이오 대학교, Exchange physician program2009년 3월 - 2010년 8월 : 경북대학교 병원 혈액종양내과 임상조교수2010년 9월 2012년 7월 : 경북대학교 병원 혈액종양내과 전임강사2012년 8월 - 현재 : 경북대학교 병원 혈액종양내과 조교수
Academic societies
- 대한내과학회 정회원대한암학회 정회원대한혈액학회 정회원대한항암요법연구회 정회원 (위암분과위원, 비뇨기분과위원)대한임상암학회 정회원미국임상암학회 (ASCO, American Society of Clinical Oncology) 정회원유럽임상암학회 (ESMO, European Society for Medical Oncology) 정회원
- Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer. PLoS One. 2015 Mar 23;10(3):e0119649.Non-platinum-based chemotherapy for treatment of advanced gastric cancer: 5-fluorouracil, taxanes, and irinotecan. World J Gastroenterol. 2014 May 14;20(18):5396-402.Tetraspanin CD151 expression associated with prognosis for patients with advanced gastric cancer. J Cancer Res Clin Oncol. 2013 Nov;139(11):1835-43.Phosphorylated AMP-activated protein kinase expression associated with prognosis for patients with gastric cancer treated with cisplatin-based adjuvant chemotherapy. Cancer Chemother Pharmacol. 2012 Nov;70(5):735-41.Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin`s lymphoma. Invest New Drugs. 2010 Aug;28(4):516-22.등 20여편
- Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib. J Clin Oncol. 2010 Mar 20;28(9):1554-9.Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck. Clin Cancer Res. 2015 Feb 1;21(3):544-52.Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence. Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):73-80.Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation. Cancer Chemother Pharmacol. 2013 Feb;71(2):551-2.Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer. Ann Surg Oncol. 2014 Dec;21 Suppl 4:S634-9.등 30여편
FAQ
- Where does Kang Byeong-uk see patients?
- In Hematology and Oncology at Kyungpook National University Hospital Chilgok. The hospital address is 807 Hoguk-ro, Buk-gu, Daegu.
- What is Kang Byeong-uk's specialty?
- Specialty: Hematology and Oncology.
Is any information wrong?
Let us know about changes to hospital, specialty, career and so on, and we'll update it after checking.